Article: Chemotherapy of human breast-carcinoma xenografts

Five lines of human breast-carcinoma xenografts have been tested for sensitivity to cyclophosphamide, methotrexate, 5-fluorouracil, adriamycin, vincristine and melphalan, alone and in combination, using tumour growth delay as an end-point. The xenograft lines were established and passaged in mice immune-suppressed by thymectomy and whole-body irradiation. There was a considerable range of sensitivity of the different lines to the agents studied, and within this variation there was evidence that the most effective single agent or combination differed for each tumour. Combination chemotherapy was more effective than single agents in 3 of the lines, but melphalan was more effective than either combination in the other 2. It is suggested that a panel of human breast tumours grown in immune-suppressed mice may prove useful in testing new cytotoxic agents for activity against breast cancer before their use in clinical trials, and that more effective combinations of existing drugs might be designed with the aid of this system.

Citing Articles

Species differences in tumour responses to cancer chemotherapy.

Lawrence J, Cameron D, Argyle D Philos Trans R Soc Lond B Biol Sci. 2015; 370(1673).

PMID: 26056373 PMC: 4581034. DOI: 10.1098/rstb.2014.0233.

17beta-Oestradiol treatment modulates nitric oxide synthase activity in MDA231 tumour with implications on growth and radiation response.

Chinje E, Williams K, Telfer B, Wood P, van der Kogel A, Stratford I Br J Cancer. 2002; 86(1):136-42.

PMID: 11857025 PMC: 2746548. DOI: 10.1038/sj.bjc.6600032.

Comparative functional histopathology of human breast carcinoma xenografts.

Bailey M, Ormerod M, Imrie S, Humphreys J, Roberts J, Gazet J Br J Cancer. 1981; 43(2):125-34.

PMID: 7470377 PMC: 2010529. DOI: 10.1038/bjc.1981.20.

In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids.

Jones A, Stratford I, Wilson P, Peckham M Br J Cancer. 1982; 46(6):870-9.

PMID: 6891260 PMC: 2011214. DOI: 10.1038/bjc.1982.296.

The response to chemotherapy of a variety of human tumour xenografts.

STEEL G, COURTENAY V, Peckham M Br J Cancer. 1983; 47(1):1-13.

PMID: 6336942 PMC: 2011242. DOI: 10.1038/bjc.1983.1.

References

1.

Brambilla C, De Lena M, Rossi A, Valagussa P, Bonadonna G . Response and survival in advanced breast cancer after two non-cross-resistant combinations. Br Med J. 1976; 1(6013):801-4. PMC: 1639498. DOI: 10.1136/bmj.1.6013.801. View

2.

Carter S . Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast. Cancer Treat Rev. 1976; 3(3):141-74. DOI: 10.1016/s0305-7372(76)80020-5. View

3.

Shimosato Y, Kameya T, Nagai K, Hirohashi S, Koide T, Hayashi H . Transplantation of human tumors in nude mice. J Natl Cancer Inst. 1976; 56(6):1251-60. DOI: 10.1093/jnci/56.6.1251. View

4.

STEEL G, COURTENAY V, Rostom A . Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978; 37(2):224-30. PMC: 2009576. DOI: 10.1038/bjc.1978.30. View

5.

Bonadonna G . Adjuvant chemotherapy of breast cancer. Br J Hosp Med. 1980; 23(1):40, 45, 48 passim. View

Chemotherapy of Human Breast-carcinoma Xenografts